KZR - Kezar Life Sciences, Inc.
6.475
0.235 3.629%
Share volume: 789
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.12%
PREVIOUS CLOSE
CHG
CHG%
$6.24
0.24
3.77%
Summary score
31%
Profitability
35%
Dept financing
4%
Liquidity
43%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-12.76%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
16.54%
Debt ratio change over timeo
-1.05%
Current Ratio
9.57%
Quick Ratio
0%
Cash Position Ratio
1.79%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-12.76%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
16.54%
Debt ratio change over timeo
-1.05%
Current Ratio
9.57%
Quick Ratio
0%
Cash Position Ratio
1.79%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-13.38%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18.31%
Debt ratio change over time
-1.05%
Current Ratio
7.65%
Quick Ratio
0%
Cash Position Ratio
1.71%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-96.39%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-104.77%
Debt ratio change over time
-1.05%
Current Ratio
-3.74%
Quick Ratio
0%
Cash Position Ratio
-1.54%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KZR | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 16.27% | 18.34% | 4.17% |
| Return on assets | -12.76% | 2.36% | 3.17% | 5.68% |
| Return on sales | 0% | 28.88% | 30.73% | 42.61% |
| Return on invested capital | 0% | 2.59% | 5.33% | 28.42% |
| Profitability | 0% | 52% | 62% | 81% |
| Total debt ratio | 16.54% | 91.15% | 91.7% | 24.48% |
| Debt ratio change over time | -1.05% | 100.91% | 17.73% | -0% |
| Dept financing | 5% | 50% | 29% | 7% |
| Current Ratio | 9.57% | 0.8% | 1.33% | 3.12% |
| Quick Ratio | 0% | 0.69% | 0.94% | 2.88% |
| Cash Position Ratio | 1.79% | 0.31% | 0.46% | 2.2% |
| Liquididy | 39% | 9% | 21% | 61% |
| Short-term ratios | KZR | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -4.29% |
| Return on assets | -12.76% | 1.74% | 2.28% | 4.72% |
| Return on sales | 0% | 25.62% | 20.05% | 39.7% |
| Return on invested capital | 0% | 0% | 0% | -3.9% |
| Profitability | 50% | 25% | 25% | 50% |
| Total debt ratio | 16.54% | 95.21% | 93.27% | 25.36% |
| Debt ratio change over time | -1.05% | 0% | 0% | -0.58% |
| Dept financing | 4% | 25% | 49% | 7% |
| Current Ratio | 9.57% | 0.8% | 1.33% | 3.12% |
| Quick Ratio | 0% | 0.69% | 0.94% | 2.88% |
| Cash Position Ratio | 1.79% | 0.31% | 0.46% | 2.2% |
| Liquididy | 45% | 12% | 17% | 58% |